Salah Abdelrazig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Salah Abdelrazig has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Dong-Hyun Kim
University of Nottingham
9 shared publications - David A. Barrett
Centre for Analytical Bioscience, Advanced Materials and Healthcare Division, School of Pharmacy, University of Nottingham, Nottingham, UK
6 shared publications - Laudina Safo
Centre for Analytical Bioscience, Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, NG7 2RD, UK
3 shared publications - Nigel Peter Minton
BBSRC/EPSRC Synthetic Biology Research Centre (SBRC), University of Nottingham , NG7 2RD, Nottingham
3 shared publications - Shady A. Amin
Division of Science, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
3 shared publications - Amal Ghaleb Al-Bakri
Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman 11942, Jordan
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3115-3132
Steroid hormones produced by coral-associated Endozoicomonas influence coral immune response during thermal stress
- 22 October 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3115-3132
Open AccessSteroid hormones produced by coral-associated Endozoicomonas influence coral immune response during thermal stress
- Open Access
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (18) , 5459-5469
Metabolic profiling reveals subtype-specific responses to jerantinine A acetate in breast cancer cells
LC-MS metabolomics reveals subtype-specific responses to jerantinine A acetate in breast cancer cells, with a distinct p53-associated antioxidant response in MCF-7 cells. Created in BioRender (https://biorender.com/ijdcg9c).
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (18) , 5459-5469
Open AccessMetabolic profiling reveals subtype-specific responses to jerantinine A acetate in breast cancer cells
LC-MS metabolomics reveals subtype-specific responses to jerantinine A acetate in breast cancer cells, with a distinct p53-associated antioxidant response in MCF-7 cells. Created in BioRender (https://biorender.com/ijdcg9c).
- Open Access
- 24 July 2025
- Published by Elsevier in Harmful Algae
- Vol. 149, 102921
Microbial community dynamics and first quantification of the toxin domoic acid in a eutrophic bay in the United Arab Emirates
- 24 July 2025
- Published by Elsevier in Harmful Algae
- Vol. 149, 102921
Open AccessMicrobial community dynamics and first quantification of the toxin domoic acid in a eutrophic bay in the United Arab Emirates
- Open Access
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (26) , 20745-20759
LC-MS Orbitrap-based metabolomics using a novel hybrid zwitterionic hydrophilic interaction liquid chromatography and rigorous metabolite identification reveals doxorubicin-induced metabolic perturbations in breast cancer cells
The Z-HILIC column enhanced LC-MS separation, sensitivity, selectivity, metabolite coverage, and stability compared to ZIC- p HILIC. The workflow enabled improved profiling of Dox-induced metabolic alterations in TNBC cells.
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (26) , 20745-20759
Open AccessLC-MS Orbitrap-based metabolomics using a novel hybrid zwitterionic hydrophilic interaction liquid chromatography and rigorous metabolite identification reveals doxorubicin-induced metabolic perturbations in breast cancer cells
The Z-HILIC column enhanced LC-MS separation, sensitivity, selectivity, metabolite coverage, and stability compared to ZIC- p HILIC. The workflow enabled improved profiling of Dox-induced metabolic alterations in TNBC cells.
- Open Access
- 13 January 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-13
LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin
Colorectal cancer (CRC) is the third most prevalent tumor in men, the second most common in women, and the fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering the function of 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes in cholesterol synthesis. Strains have shown anticancer effects against CRC. However, statins’ anticancer mechanism is yet unknown. Liquid chromatography–mass spectrometry (LC–MS)-based untargeted metabolomics and proteomics were employed to study statins’ effects on CRC using the CRC cell line HCT-116. These approaches were utilized to identify potential underlying metabolic pathways and proteins altered in atorvastatin (a statin)-treated HCT-116 cells. Compared to the control, atorvastatin significantly altered numerous metabolites in HCT-116 cells, including a reduction in the levels of decanoylcarnitine and octanoyl-L-carnitine and in the biosynthesis and metabolism of amino acids like alanine and citrate cycle. Proteomic study showed that atorvastatin-treated HCT-116 cells expressed 127 proteins differently from controls. Novel findings were among them, such as centromere-associated protein E, cytochrome c oxidase subunit 6A1 mitochondrial, and hyaluronan synthase 1. The findings indicate that atorvastatin may have potential anticancer characteristics and highlight the essential role metabolomics and proteomics to understand complex metabolic pathways and proteins relevant to cancer and develop novel treatment targets.
- 13 January 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-13
Open AccessLC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin
Colorectal cancer (CRC) is the third most prevalent tumor in men, the second most common in women, and the fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering the function of 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes in cholesterol synthesis. Strains have shown anticancer effects against CRC. However, statins’ anticancer mechanism is yet unknown. Liquid chromatography–mass spectrometry (LC–MS)-based untargeted metabolomics and proteomics were employed to study statins’ effects on CRC using the CRC cell line HCT-116. These approaches were utilized to identify potential underlying metabolic pathways and proteins altered in atorvastatin (a statin)-treated HCT-116 cells. Compared to the control, atorvastatin significantly altered numerous metabolites in HCT-116 cells, including a reduction in the levels of decanoylcarnitine and octanoyl-L-carnitine and in the biosynthesis and metabolism of amino acids like alanine and citrate cycle. Proteomic study showed that atorvastatin-treated HCT-116 cells expressed 127 proteins differently from controls. Novel findings were among them, such as centromere-associated protein E, cytochrome c oxidase subunit 6A1 mitochondrial, and hyaluronan synthase 1. The findings indicate that atorvastatin may have potential anticancer characteristics and highlight the essential role metabolomics and proteomics to understand complex metabolic pathways and proteins relevant to cancer and develop novel treatment targets.
- Open Access
- 1 June 2024
- Published by KEAI Publishing in Engineered Regeneration
- Vol. 5 (2) , 255-268
Sustained adenosine release: Revealing its impact on osteogenic signalling pathways of human mesenchymal stromal cells
- 1 June 2024
- Published by KEAI Publishing in Engineered Regeneration
- Vol. 5 (2) , 255-268
Open AccessSustained adenosine release: Revealing its impact on osteogenic signalling pathways of human mesenchymal stromal cells
- Open Access
- 6 June 2023
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (24) , 2925-2934
Advantages of using biologically generated 13C-labelled multiple internal standards for stable isotope-assisted LC-MS-based lipidomics
An in vivo multiple labelling strategy using P. pastoris to generate 300 + 13C-labelled internal standards was shown to significantly reduce technical variations introduced in typical human lipidomics analyses using >100 samples and >70 h run time.
- 6 June 2023
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (24) , 2925-2934
Open AccessAdvantages of using biologically generated 13C-labelled multiple internal standards for stable isotope-assisted LC-MS-based lipidomics
An in vivo multiple labelling strategy using P. pastoris to generate 300 + 13C-labelled internal standards was shown to significantly reduce technical variations introduced in typical human lipidomics analyses using >100 samples and >70 h run time.
- Open Access
- 20 February 2023
- Published by Springer Nature in AMB Express
- Vol. 13 (1) , 1-17
Micafungin effect on Pseudomonas aeruginosa metabolome, virulence and biofilm: potential quorum sensing inhibitor
The prevalence of antibiotic resistance in Pseudomonas aeruginosa places a heavy burden on the health care sectors urging the need to find alternative, non-antibiotic strategies. The interference with the P. aeruginosa quorum sensing (QS) system represents a promising alternative strategy to attenuate the bacterial virulency and its ability to form biofilms. Micafungin has been reported to impede the pseudomonal biofilm formation. However, the influences of micafungin on the biochemical composition and metabolites levels of P. aeruginosa have not been explored. In this study, the effect of micafungin (100 µg/mL) on the virulence factors, QS signal molecules and the metabolome of P. aeruginosa was studied using exofactor assay and mass spectrometry-based metabolomics approaches. Furthermore, confocal laser scanning microscopy (CLSM) using the fluorescent dyes ConA-FITC and SYPRO® Ruby was used to visualize micafungin disturbing effects on the pseudomonal glycocalyx and protein biofilm-constituents, respectively. Our findings showed that micafungin significantly decreased the production of various QS-controlled virulence factors (pyocyanin, pyoverdine, pyochelin and rhamnolipid), along with a dysregulation in the level of various metabolites involved in QS system, lysine degradation, tryptophan biosynthesis, TCA cycle, and biotin metabolism. In addition, the CLSM examination showed an altered matrix distribution. The presented findings highlight the promising role of micafungin as a potential quorum sensing inhibitor (QSI) and anti-biofilm agent to attenuate P. aeruginosa pathogenicity. In addition, they point to the promising role of metabolomics study in investigating the altered biochemical pathways in P. aeruginosa.
- 20 February 2023
- Published by Springer Nature in AMB Express
- Vol. 13 (1) , 1-17
Open AccessMicafungin effect on Pseudomonas aeruginosa metabolome, virulence and biofilm: potential quorum sensing inhibitor
The prevalence of antibiotic resistance in Pseudomonas aeruginosa places a heavy burden on the health care sectors urging the need to find alternative, non-antibiotic strategies. The interference with the P. aeruginosa quorum sensing (QS) system represents a promising alternative strategy to attenuate the bacterial virulency and its ability to form biofilms. Micafungin has been reported to impede the pseudomonal biofilm formation. However, the influences of micafungin on the biochemical composition and metabolites levels of P. aeruginosa have not been explored. In this study, the effect of micafungin (100 µg/mL) on the virulence factors, QS signal molecules and the metabolome of P. aeruginosa was studied using exofactor assay and mass spectrometry-based metabolomics approaches. Furthermore, confocal laser scanning microscopy (CLSM) using the fluorescent dyes ConA-FITC and SYPRO® Ruby was used to visualize micafungin disturbing effects on the pseudomonal glycocalyx and protein biofilm-constituents, respectively. Our findings showed that micafungin significantly decreased the production of various QS-controlled virulence factors (pyocyanin, pyoverdine, pyochelin and rhamnolipid), along with a dysregulation in the level of various metabolites involved in QS system, lysine degradation, tryptophan biosynthesis, TCA cycle, and biotin metabolism. In addition, the CLSM examination showed an altered matrix distribution. The presented findings highlight the promising role of micafungin as a potential quorum sensing inhibitor (QSI) and anti-biofilm agent to attenuate P. aeruginosa pathogenicity. In addition, they point to the promising role of metabolomics study in investigating the altered biochemical pathways in P. aeruginosa.
- Open Access
- 12 August 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (33) , 28806-28819
Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics
Polymeric nanoparticles (NPs) are widely used in preclinical drug delivery investigations, and some formulations are now in the clinic. However, the detailed effects of many NPs at the subcellular level have not been fully investigated. In this study, we used differentiated THP-1 macrophage cells, as a model, to investigate the metabolic changes associated with the use of poly (lactic-co-glycolic acid) (PLGA) NPs with different surface coating or conjugation chemistries. Liquid chromatography-mass spectrometry-based metabolic profiling was performed on the extracts (n = 6) of the differentiated THP-1 cells treated with plain, Pluronic (F-127, F-68, and P-85)-coated and PEG-PLGA NPs and control (no treatment). Principal component analysis and orthogonal partial least squares-discriminant analysis (OPLS-DA) in conjunction with univariate and pathway analyses were performed to identify significantly changed metabolites and pathways related to exposure of the cells to NPs. OPLS-DA of each class in the study compared to the control showed clear separation and clustering with cross-validation values of R 2 and Q 2 > 0.5. A total of 105 metabolites and lipids were found to be significantly altered in the differentiated THP-1 cell profiles due to the NP exposure, whereas more than 20 metabolic pathways were found to be affected. These pathways included glycerophospholipid, sphingolipid, linoleic acid, arginine and proline, and alpha-linolenic acid metabolisms. PLGA NPs were found to perturb some amino acid metabolic pathways and altered membrane lipids to a different degree. The metabolic effect of the PLGA NPs on the cells were comparable to those caused by silver oxide NPs and other inorganic nanomaterials. However, PEG-PLGA NPs demonstrated a reduced impact on the cellular metabolism compared to Pluronic copolymer-coated PLGA and plain PLGA NPs.
- 12 August 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (33) , 28806-28819
Open AccessMetabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics
Polymeric nanoparticles (NPs) are widely used in preclinical drug delivery investigations, and some formulations are now in the clinic. However, the detailed effects of many NPs at the subcellular level have not been fully investigated. In this study, we used differentiated THP-1 macrophage cells, as a model, to investigate the metabolic changes associated with the use of poly (lactic-co-glycolic acid) (PLGA) NPs with different surface coating or conjugation chemistries. Liquid chromatography-mass spectrometry-based metabolic profiling was performed on the extracts (n = 6) of the differentiated THP-1 cells treated with plain, Pluronic (F-127, F-68, and P-85)-coated and PEG-PLGA NPs and control (no treatment). Principal component analysis and orthogonal partial least squares-discriminant analysis (OPLS-DA) in conjunction with univariate and pathway analyses were performed to identify significantly changed metabolites and pathways related to exposure of the cells to NPs. OPLS-DA of each class in the study compared to the control showed clear separation and clustering with cross-validation values of R 2 and Q 2 > 0.5. A total of 105 metabolites and lipids were found to be significantly altered in the differentiated THP-1 cell profiles due to the NP exposure, whereas more than 20 metabolic pathways were found to be affected. These pathways included glycerophospholipid, sphingolipid, linoleic acid, arginine and proline, and alpha-linolenic acid metabolisms. PLGA NPs were found to perturb some amino acid metabolic pathways and altered membrane lipids to a different degree. The metabolic effect of the PLGA NPs on the cells were comparable to those caused by silver oxide NPs and other inorganic nanomaterials. However, PEG-PLGA NPs demonstrated a reduced impact on the cellular metabolism compared to Pluronic copolymer-coated PLGA and plain PLGA NPs.